« Back
Home /
GSK1838705A

GSK1838705A

Manufacturer	MedChem Express
Category	Oncology Neuroscience Metabolism Diabetes Cholesterol & Lipid Metabolism Regulation of Appetite Molecular Targets for Neuroscience Inhibitors & Compound Libraries Small Molecules By Organ Lung Cancer Skin Cancer Lymphatic System Cancer
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	5 mg
Item no.	HY-13020-5mg
Targets	ALK
CASRN	1116235-97-2
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	GSK1838705A is a potent and reversible IGF-IR and the insulin receptor inhibitor with IC50s of 2.0 and 1.6 nM, respectively. It also inhibits ALK with an IC50 of 0.5 nM.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	532.57
Clinical_Information	No Development Reported
Manufacturers Research_Area	Cancer; Endocrinology
Solubility	DMSO : ≥ 100 mg/mL
Pathway	Protein Tyrosine Kinase/RTK
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-13020-5mg-safety-datasheet.pdf